These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Full exploration of the Diels-Alder cycloaddition on metallofullerenes M3N@C80 (M = Sc, Lu, Gd): the D(5h) versus I(h) isomer and the influence of the metal cluster. Osuna S; Valencia R; Rodríguez-Fortea A; Swart M; Solà M; Poblet JM Chemistry; 2012 Jul; 18(29):8944-56. PubMed ID: 22692922 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors. Chen J; Linder KE; Cagnolini A; Metcalfe E; Raju N; Tweedle MF; Swenson RE Appl Radiat Isot; 2008 Apr; 66(4):497-505. PubMed ID: 18178448 [TBL] [Abstract][Full Text] [Related]
11. Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Fatouros PP; Corwin FD; Chen ZJ; Broaddus WC; Tatum JL; Kettenmann B; Ge Z; Gibson HW; Russ JL; Leonard AP; Duchamp JC; Dorn HC Radiology; 2006 Sep; 240(3):756-64. PubMed ID: 16837672 [TBL] [Abstract][Full Text] [Related]
13. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation. Abbasi IA Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790 [TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis. Trujillo-Nolasco RM; Morales-Avila E; Ocampo-García BE; Ferro-Flores G; Gibbens-Bandala BV; Escudero-Castellanos A; Isaac-Olive K Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109766. PubMed ID: 31349410 [TBL] [Abstract][Full Text] [Related]
16. 2-Aminoethanol Extraction as a Method for Purifying Sc3N@C80 and for Differentiating Classes of Endohedral Fullerenes on the Basis of Reactivity. Sarina EA; Mercado BQ; Franco JU; Thompson CJ; Easterling ML; Olmstead MM; Balch AL Chemistry; 2015 Nov; 21(47):17035-43. PubMed ID: 26437717 [TBL] [Abstract][Full Text] [Related]
17. Highly regioselective derivatization of trimetallic nitride templated endohedral metallofullerenes via a facile photochemical reaction. Shu C; Slebodnick C; Xu L; Champion H; Fuhrer T; Cai T; Reid JE; Fu W; Harich K; Dorn HC; Gibson HW J Am Chem Soc; 2008 Dec; 130(52):17755-60. PubMed ID: 19055362 [TBL] [Abstract][Full Text] [Related]
18. Science to practice: can theranostic fullerenes be used to treat brain tumors? Bulte JW Radiology; 2011 Oct; 261(1):1-2. PubMed ID: 21931135 [TBL] [Abstract][Full Text] [Related]
19. An endohedral redox system in a fullerene cage: the Ce based mixed-metal cluster fullerene Lu2CeN@C80. Zhang L; Popov AA; Yang S; Klod S; Rapta P; Dunsch L Phys Chem Chem Phys; 2010 Jul; 12(28):7840-7. PubMed ID: 20532305 [TBL] [Abstract][Full Text] [Related]
20. Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with (177)Lu and Conjugated to Peptides. Ferro-Flores G; Ocampo-García BE; Santos-Cuevas CL; de María Ramírez F; Azorín-Vega EP; Meléndez-Alafort L Curr Radiopharm; 2015; 8(2):150-9. PubMed ID: 25771363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]